Pfizer Inc PFE and BioNTech SE BNTX have announced results from a Phase 2/3 trial of a 10 µg booster (third) dose of COVID-19 vaccine in children aged 5-11 years.
The data demonstrate an increase in omicron variant and wild-type strain neutralizing titers following a booster dose compared to two doses, reinforcing the potential in maintaining high levels of protection against the virus in this age group.
In the Phase 2/3 trial, data comes from 140 children 5 through 11 years who received a booster dose approximately 6 months after the second dose of the 10 µg primary series.
Data from a subanalysis of 30 sera indicate that serum antibodies induced by a third dose neutralize the omicron variant. It demonstrated a 36-fold increase in neutralizing antibody titers compared to levels seen after two vaccine doses.
Further, immunogenicity data from the 140 participants who had no evidence of prior infection showed a 6-fold increase in wild-type strain–neutralizing geometric mean titers one month after the booster compared to one month after the second dose.
Pfizer and BioNTech plan to submit a request for Emergency Use Authorization (EUA) for a booster dose for children ages 5 through 11 in the U.S. in the coming days.
Price Action: PFE shares are down 0.15% at $53.02, BNTX stock is down 0.45% at $178.58 during premarket trading.
Photo by x3 from Pixabay
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.